Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Prevention of Brain Injury in Preterm Infants
NCT00065949Phase 3Unknown
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Aug 1987
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of magnesium sulfate in traumatic brain injury (TBI) and cerebral palsy (CP) (2 arms), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Primary endpoints: Early brain injury (intracranial hemorrhage and cystic periventricular leukomalacia) and Presence of cerebral palsy at 24 months. Status: unknown.
02
Drugs
magnesium sulfate
03
Conditions
traumatic brain injury (TBI)cerebral palsy (CP)
Beyond the preview
Go deeper on NCT00065949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00065949.